![Treatment For Latent TB(Tuberculosis) Infection Isoniazid (INH) | The Windsor-Essex County Health Unit Treatment For Latent TB(Tuberculosis) Infection Isoniazid (INH) | The Windsor-Essex County Health Unit](https://www.wechu.org/sites/default/files/tb/tb-brochure.jpg)
Treatment For Latent TB(Tuberculosis) Infection Isoniazid (INH) | The Windsor-Essex County Health Unit
![12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other 12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other](https://npin.cdc.gov/sites/default/files/images/publications/12-dose_regimen_fact_sheet1_0.jpg)
12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other
![Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other](https://npin.cdc.gov/sites/default/files/images/publications/treatment_for_ltbi_-_inh-rpt.png)
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
![Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/6/1563/F1.large.jpg)
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society
![Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/269377/lightbox_c5fb36107b3911ec8bbc7768c1ce16cf-FlowChart1-2-.png)
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
![Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/5/1397/F4.large.jpg?width=800&height=600&carousel=1)
Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society
![A Lazy Person's Guide to Latent Tuberculosis Treatment in Patients with HIV - Southeast AIDS Education & Training Center A Lazy Person's Guide to Latent Tuberculosis Treatment in Patients with HIV - Southeast AIDS Education & Training Center](https://www.seaetc.com/wp-content/uploads/2021/01/Recommended-Treatment-for-LTBI.png)